Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Doctors urged to ditch blue inhalers for asthma treatment over climate concerns - New guidelines say ‘greenhouse gas effect’ ...